Highlights: GLP-1 users had a 37% higher hair loss risk than SGLT-2 inhibitor users, although the overall risk remained low Most cases involved temporary, non-scarring hair loss linked to rapid weight loss and nutritional changes Experts recommend maintaining good nutrition and consulting a doctor rather than stopping GLP-1 treatment Weight loss drugs called GLP-1 receptor agonists, including Ozempic, Wegovy, Mounjaro, and Zepbound, are transforming the treatment of obesity and type 2 diabetes by improving blood sugar control and promoting substantial weight loss
The Potential Pros of Microdosing GLP-1s The true potential benefit of microdosing may have nothing to do with weight loss
Protects against oxidative stress Packed with synergistic antioxidants that combat free radicals, it supports cellular health and promotes healthy ageing
Always consult a qualified healthcare provider before starting, stopping, or changing any peptide, hormone, or wellness treatment.
Las tasas de discontinuacin del tratamiento debido a eventos adversos fueron del 8,7% y el 9,7% con orforglipron 12 mg y 36 mg , frente al 4,5% y el 4,9% con semaglutida oral en ACHIEVE-3